| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
GPCR
Structure Therapeutics, Inc. Sponsored ADR
|
Jun 09, 2026 | BUY |
Strong Buy
+129.9% avg upside
17 analysts
|
— | · |
|
KLRA
Kailera Therapeutics, Inc.
|
May 12, 2026 | BUY |
Strong Buy
+103.9% avg upside
5 analysts
|
$30.00
56.89% Upside
|
· |
|
PCRX
Pacira Pharmaceuticals
|
Mar 20, 2026 | SELL |
Buy
+72.5% avg upside
21 analysts
|
$23.00
1.51% Upside
|
-4.0% |
|
VKTX
Viking Therapeutics
|
Feb 11, 2026 | BUY |
Strong Buy
+141.0% avg upside
30 analysts
|
$75.00
147.63% Upside
|
+3.9% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.